Short Interest in Zentek Ltd. (NASDAQ:ZTEK) Declines By 25.1%

Zentek Ltd. (NASDAQ:ZTEK) was the target of a significant decrease in short interest during the month of February. As of February 28th, there was short interest totalling 148,000 shares, a decrease of 25.1% from the February 13th total of 197,500 shares. Based on an average trading volume of 45,800 shares, the days-to-cover ratio is currently 3.2 days. Currently, 0.2% of the shares of the stock are sold short.

Zentek Trading Down 0.2 %

Shares of ZTEK stock opened at $0.92 on Monday. The business has a 50-day moving average price of $1.05 and a two-hundred day moving average price of $0.95. Zentek has a 12-month low of $0.50 and a 12-month high of $1.34. The company has a quick ratio of 1.48, a current ratio of 1.83 and a debt-to-equity ratio of 0.01. The firm has a market cap of $95.76 million, a P/E ratio of -13.11 and a beta of 1.30.

Zentek (NASDAQ:ZTEK) last posted its quarterly earnings results on Wednesday, February 12th. The company reported ($0.01) EPS for the quarter. Zentek had a negative return on equity of 58.13% and a negative net margin of 16,555.32%.

Hedge Funds Weigh In On Zentek

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Two Sigma Securities LLC bought a new stake in Zentek during the 4th quarter valued at $31,000. Anson Funds Management LP bought a new stake in shares of Zentek in the fourth quarter worth about $145,000. Finally, Scotia Capital Inc. increased its holdings in Zentek by 5.7% during the 4th quarter. Scotia Capital Inc. now owns 958,771 shares of the company’s stock valued at $867,000 after purchasing an additional 51,744 shares during the period. 0.77% of the stock is currently owned by institutional investors.

About Zentek

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.